Figure 6From: The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393] Effect of simvastatin allocation on first major vascular event in participants subdivided by presenting features. Symbols and conventions as in Figures 1 & 5.Back to article page
